repaglinide glp 1 Risk of hypoglycemia associated with combined with clopidogrel, a retrospective cohort study | Journal of Pharmaceutical Health Care and Sciences Glucagon-Like Peptide 1 Receptor Agonist

[DOI] [PubMed] [Google Scholar] Zipser Y, Piade A, Kosower NS

While semaglutide did not reduce incident COVID-19, among participants who developed COVID-19, those who were treated with semaglutide had fewer COVID-19-related adverse events or died from COVID-19

Vargas MR, Pehar M, Cassina P, Martnez-Palma L, Thompson JA, Beckman JS, et al

Fioretto P, Trevisan R, Velussi M, Cernigoi A, De Riva C, Bressan M, et al

Detection of GSTP1/2, NRF2 and MnSOD were performed on paraffin sections by using anti-GSTpi (PB13020, Abnova, Tebu Bio Sas, Le Perray en Yvelines, France), anti-NRF2 (sc-722, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-MnSOD (D3X8F, Cell Signaling Technology, Beverly, MA, USA), respectively